Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks

Overview of attention for article published in HIV/AIDS (Auckland, N.Z.), March 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 22,183 followers.

No gender differences of HIV-1 treated with abacavir/lamivudine+atazanavir, with/without ritonavir, for 144 weeks. https://t.co/wb6UPjN5Xt

Reply Repost Favourite